BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9636691)

  • 1. In vitro thymocyte maturation is associated with reduced cellular susceptibility to Fas-mediated apoptosis.
    Hershberger PA; He H; McCarthy SA
    Cell Immunol; 1998 May; 185(2):134-45. PubMed ID: 9636691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.
    Jenkins M; Keir M; McCune JM
    J Immunol; 1999 Aug; 163(3):1195-204. PubMed ID: 10415014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
    Zhang J; Cado D; Chen A; Kabra NH; Winoto A
    Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
    Van Parijs L; Biuckians A; Abbas AK
    J Immunol; 1998 Mar; 160(5):2065-71. PubMed ID: 9498742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways.
    Kim K; Lee CK; Sayers TJ; Muegge K; Durum SK
    J Immunol; 1998 Jun; 160(12):5735-41. PubMed ID: 9637482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
    Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
    J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway.
    Chiarle R; Podda A; Prolla G; Podack ER; Thorbecke GJ; Inghirami G
    J Immunol; 1999 Jul; 163(1):194-205. PubMed ID: 10384116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis.
    Zhang H; Taylor J; Luther D; Johnston J; Murray S; Wyatt JR; Watt AT; Koo S; York-DeFalco C; Stecker K; Dean NM
    J Pharmacol Exp Ther; 2003 Oct; 307(1):24-33. PubMed ID: 12893848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.
    Algeciras-Schimnich A; Griffith TS; Lynch DH; Paya CV
    J Immunol; 1999 May; 162(9):5205-11. PubMed ID: 10227994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
    Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel Bax-associated protein expressed in hemopoietic tissues and regulated during thymocyte apoptosis.
    He H; Hershberger PA; McCarthy SA
    J Immunol; 1998 Aug; 161(3):1169-75. PubMed ID: 9686576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells.
    You KR; Shin MN; Park RK; Lee SO; Kim DG
    Hepatology; 2001 Dec; 34(6):1119-27. PubMed ID: 11732001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-x protects primary B cells against Fas-mediated apoptosis.
    Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
    J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone induces apoptosis of thymocyte through Fas/Fas-L pathway.
    Liang J; Yao G; Yang L; Hou Y
    Int Immunopharmacol; 2004 Nov; 4(12):1467-75. PubMed ID: 15351316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of Thy-1 glycoprotein induces thymocyte apoptosis through activation of CPP32-like proteases.
    Fujita N; Kodama N; Kato Y; Lee SH; Tsuruo T
    Exp Cell Res; 1997 May; 232(2):400-6. PubMed ID: 9168818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents.
    Schwarz YX; Yang My; Qin D; Wu J; Jarvis WD; Grant S; Burton GF; Szakal AK; Tew JG
    J Immunol; 1999 Dec; 163(12):6442-7. PubMed ID: 10586034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.